Ovid Therapeutics (OVID) Q1 2023 Earnings

5MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.25
-0.22
-0.19
-0.16

Details

Expected EPS
-0.17
Actual EPS
-0.19
Surprise EPS
-0.02
Surprise Percent
+11.76%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.19 per share for Q1 2023.

0 Comments

Share your thoughts